Portnoy, A; CLARK, RA; Weerasuriya, CK; Mukandavire, C; Quaife, M; Bakker, R; Garcia Baena, I; Gebreselassie, N; Zignol, M; JIT, M; WHITE, RG; Menzies, NA;
BMJ global health, (2023).8 7
Chalet, F-X; Bujaroska, T; Germeni, E; Ghandri, N; Maddalena, ET; Modi, K; Olopoenia, A; Thompson, J; Togninalli, M; BRIGGS, AH;
PharmacoEconomics - open, (2023).7 1
Mwenda, V; Jalang'o, R; Miano, C; Bor, J-P; Nyangasi, M; Mecca, L; Were, V; Kariithi, E; Pecenka, C; Schuind, A; ABBAS, K; CLARK, A;
PIF influenza costing analysis and probabilistic sensitivity analysis.
Tang, FF-Y; Kosana, P; JIT, M; TERRIS-PRESTHOLT, F; WU, D; Ong, JJ; TUCKER, JD;
, PLOS Global Public Health (2023).
Agravat, P; Loucaides, EM; KUMAR, MB; Howells, A; GarcÃa, AM; Sebina, I; Balanza, N; FITCHETT, EJ A; LAWN, JE;
The Lancet Global health, (2023).11 11
Fleming, JA; Baral, R; Higgins, D; Khan, S; Kochar, S; Li, Y; Ortiz, JR; Cherian, T; Feikin, D; JIT, M; Karron, RA; Limaye, RJ; Marshall, C; Munywoki, PK; Nair, H; Newhouse, LC; Nyawanda, BO; Pecenka, C; Regan, K; Srikantiah, P; Wittenauer, R; Zar, HJ; Sparrow, E;
Vaccine, (2023).41 Suppl 2,
PIF influenza participant questionnaire responses and donation amounts dataset.
Tang, FF-Y; Kosana, P; JIT, M; TERRIS-PRESTHOLT, F; WU, D; Ong, JJ; TUCKER, JD;
, PLOS Global Public Health (2023).
Baltussen, R; Surgey, G; VASSALL, A; Norheim, OF; Chalkidou, K; Siddiqi, S; Nouhi, M; Youngkong, S; Jansen, M; Bijlmakers, L; Oortwijn, W;
Cost effectiveness and resource allocation : C/E, (2023).21 1
Megiddo, I; Blair, S; Sabei, D; RUIZ, F; Morton, AD;
Gao, J; Fan, J; Zhou, H; JIT, M; Wang, P;
BMJ paediatrics open, (2023).7 1
